Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

Start-up Spotlight: Multimmune GmbH

Posted on November 18th, 2016 by in Pharma R&D

Munich-based biopharma start-up multimmune GmbH is in our spotlight this week due to the company’s inspired research efforts. Professor A. Graham Pockley, Chief Executive Officer of multimmune, discusses how they are working towards the development of more cost-effective cancer treatments. Continue reading “Start-up Spotlight: Multimmune GmbH” »